Novel curcumin (CUR)-loaded cellulose acetate phthalate (CAP) nonwoven electrospun nanofiber (NF) transdermal mat was developed and evaluated for its CUR diffusion properties. Various CAP solutions from 5 to 20 wt% were tested; 17.5 wt% was found to be a suitable concentration for NF fabrication without defects, such as bubble or ribbon structures. The selected wt% CAP solution was loaded with CUR and electrospun into NFs. The prepared CUR-loaded NFs were characterized using scanning electron microscopy, X-ray diffraction, ultraviolet-visible spectroscopy, thermogravimetric analysis (TGA), and diffusion studies. The as-prepared fibers demonstrated controlled transdermal delivery of CUR for up to 24 h.
To enhance the solubility of Repaglinide, we attempted to use Plasdone S 630, a novel solubility enhancer. Followed by the hot-melt extrusion method and made into a tablet dosage form. The prepared dosage forms subjected to all pre-compression and post-compression parameters evaluations. The data obtained from in-vitro drug release suggested that the trial-11 is the ideal formulation among all other formulations. The in-vitro release was also profiling around 95% within 45 minutes. The hardness of the prepared tablets was around 10-12 kg/cm 2 with the friability was less than 1%. So, this method could apply on the regular basis for formulating the tablet dosage forms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.